Related Experiment Video
Updated: Jun 28, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Changing clinical characteristics of pediatric inpatients with pneumonia during COVID-19 pandamic: a retrospective
Mengxue Chen1, Yabing Zhou2, Shengjie Jin3
1Department of Pediatric Pulmonology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, 200092, Shanghai, China.
Insights
The COVID-19 pandemic reduced pediatric pneumonia hospitalizations and common infections. Allergy rates and deficiencies in vitamins B2, B6, C, and D increased in children.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Nutritional Science
Background:
- The COVID-19 pandemic significantly altered pathogen prevalence and lifestyle.
- Understanding these changes in pediatric pneumonia is crucial.
Purpose of the Study:
- To compare pathogen, allergen, and micronutrient profiles in pediatric pneumonia patients before and during the COVID-19 pandemic.
- To identify risk factors for severe pneumonia in this context.
Main Methods:
- Retrospective analysis of pediatric pneumonia inpatients from March-August 2019 and March-August 2020.
- Comparison of clinical characteristics, pathogen detection, allergen positivity, and micronutrient levels between the two periods.
Main Results:
- Hospitalizations for pediatric pneumonia decreased by 74% during the pandemic.
- Lower rates of viral, Mycoplasma pneumoniae, and mixed infections were observed.
- Increased positive rates for house dust mite, shrimp, and crab allergens.
- Decreased levels of vitamins B2, B6, C, and 25-hydroxyvitamin D.
- Milk allergy and calcium insufficiency were identified as risk factors for severe pneumonia.
Conclusions:
- The COVID-19 pandemic led to a reduction in pediatric pneumonia hospitalizations and common pathogen infections.
- Significant shifts in allergy profiles and micronutrient status were observed in pediatric pneumonia patients.
- These findings highlight the pandemic's impact on pediatric respiratory health and nutritional status.
Background:
The COVID-19 pandemic have impacts on the prevalence of other pathogens and people's social lifestyle. This study aimed to compare the pathogen, allergen and micronutrient characteristics of pediatric inpatients with pneumonia prior to and during the COVID-19 pandemic in a large tertiary hospital in Shanghai, China.
Methods:
Patients with pneumonia admitted to the Department of Pediatric Pulmonology of Xinhua Hospital between March-August 2019 and March-August 2020 were recruited. And clinical characteristics of the patients in 2019 were compared with those in 2020.
Results:
Hospitalizations for pneumonia decreased by 74% after the COVID-19 pandemic. For pathogens, virus, mycoplasma pneumoniae (MP) and mixed infection rates were all much lower in 2020 than those in 2019 (P < 0.01). Regarding allergens, compared with 2019, the positive rates of house dust mite, shrimp and crab were significantly higher in 2020 (P < 0.01). And for micronutrients, the levels of vitamin B2, B6, C and 25-hydroxyvitamin D (25(OH)D) in 2020 were observed to be significantly lower than those in 2019 (P < 0.05). For all the study participants, longer hospital stay (OR = 1.521, P = 0.000), milk allergy (OR = 6.552, P = 0.033) and calcium (Ca) insufficiency (OR = 12.048, P = 0.019) were identified as high-risk factors for severe pneumonia by multivariate analysis.
Conclusions:
The number of children hospitalized with pneumonia and incidence of common pathogen infections were both reduced, and that allergy and micronutrient status in children were also changed after the outbreak of the COVID-19 pandemic.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...